Juexuan Wang

Juexuan has worked in the field of molecular and cellular genetics for over 10 years. She undertook her PhD at the Wellcome Trust Sanger Institute at Cambridge.

During her study and post-doctoral research afterward, she gained experience in the functional evaluation of disease-related genes by generating genetically modified mouse models, as well as the interrogation of the signaling networks that the target genes are involved in by performing genomic analysis.

Juexuan joined PetMedix in 2018, and her current role is the Head of Antibody Discovery. Her responsibilities include overseeing the performance of the antibody discovery pipeline, from cell sorting, NGS to candidate selection and synthesis. She’s also overseeing the progress of various antibody discovery projects at PetMedix.